Search company, investor...
Translate Bio company logo

Translate Bio

translate.bio

Stage

Acq - P2P | Acquired

Total Raised

$150.51M

Valuation

$0000 

About Translate Bio

Translate Bio (NASDAQ: TBIO), formerly RaNA Therapeutics, is a biotechnology company committed to the development of next generation RNA-targeted medicines. The company's mission is to improve the lives of people suffering from serious life-altering diseases by creating precision medicines that can change the course of their condition.

Headquarters Location

29 Hartwell Ave

Lexington, Massachusetts, 02421,

United States

617-945-7361

Missing: Translate Bio's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Translate Bio's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Translate Bio

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Translate Bio in 1 CB Insights research brief, most recently on Feb 3, 2021.

Expert Collections containing Translate Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Translate Bio is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Translate Bio Patents

Translate Bio has filed 1 patent.

The 3 most popular patent topics include:

  • Molecular biology
  • Gene expression
  • RNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/26/2020

11/15/2022

Molecular biology, Drug delivery devices, Dosage forms, Membrane biology, Biotechnology

Grant

Application Date

8/26/2020

Grant Date

11/15/2022

Title

Related Topics

Molecular biology, Drug delivery devices, Dosage forms, Membrane biology, Biotechnology

Status

Grant

Latest Translate Bio News

Global mRNA Platform Market: Arcturus Therapeutic, Argos Therapeutics, BioNTec

Nov 18, 2022

Global mRNA Platform Market: Arcturus Therapeutic, Argos Therapeutics, BioNTec Pune, Maharashtra, November 18 2022 (Wiredrelease) Market.Biz –:Global Key Players In mRNA Platform Market Include Arcturus Therapeutic; Argos Therapeutics; BioNTec; CureVac; Etherna; Ethris; GlaxoSmithKline; Pfizer; Translate Bio, etc. The global mRNA Platform Market was worth USD 3998 million in 2022. It is expected to grow at a compound annual rate (CAGR of 1.9%) between 2023 and 2030. This gaining a lot of attention due to its potential for treating chronic diseases. RNA vaccines offer many advantages over DNA vaccines in terms of production, distribution, as well as safety. They have also been shown to be effective in clinical trials with humans, which has increased demand for mRNA therapeutics and vaccines. Market.Biz has recently published a research report on Global mRNA Platform Market Growth Trends and Competitive Analysis, It will provide a comprehensive overview of the mRNA Platform Market Dynamics. They have provided deep insights into key factors that influence growth. The industry forecasts and estimates were also accurately and reliably provided by the researchers. The report’s buyers will have access to the global mRNA Platform data based on volume and value. The report will help readers understand the dynamics of the future and its impact on it. Interested in this report? Fill Out Details To Receive Sample Report PDF: https://market.biz/report/global-mrna-platform-market-gm/#requestforsample Market Key Trends for mRNA Platform: This section will give readers a clear understanding of the past, upcoming and recent trends. This section will assist players in identifying these opportunities and maximizing them to strengthen their position over the coming years. They will be able to identify risks and solve tough problems in the new landscape. Covid Impact Study: This study will help you understand the effects of the Covid-19 pandemic. The research report covers aspects such as supply chain management, demand, production, export, and import. Market.Biz has also examined the factors that will help the mRNA Platform industry to gain momentum and facilitate growth over the next years. Market Segmental Study for mRNA Platform: This research report was analyzed by type and application segments. This section examines the growth opportunities each segment will have in the coming years. The analysts have performed an mRNA Platform sales analysis for each type of segment, and have provided reliable data regarding revenue and volume for 2016-2030. The report also includes a sales forecast and analysis of each type of segment and application segment, based on the volume of 2016-2030. Segment by Type: Segment by Application Infectious Disease Cancer Buy This Premium Research Report (Single User Licence: US$ 3300 Or Multi User Licence: US$ 4890 Or Corporate User: US$ 6500): https://market.biz/checkout/?reportId=839961&type=Single%20User Regional Study: This report examines the key regions of North America, Europe, Asia Pacific, Latin America, The Middle East, and Africa. This section has highlighted key factors that play a role in regional growth. Our team of experts and analysts has provided forecasts and estimates at the country and regional levels. This section discusses the mRNA Platform’s regional and country sales growth for the period 2016-2022. The researchers have done reliable volume analysis by region and sales volume analysis by country for the period 2016-2030. To give the reader a clear understanding, the mRNA Platform report includes production capacity statistics. Market Competition: Report authors have a detailed analysis of each major player in the mRNA Platform market. The report includes detailed data on the value, sales, ex-factory price, revenue, and share of manufacturers over the period 2016-2030. A detailed revenue and price analysis for all mRNA Platform manufacturers worldwide will be available to the readers in the period 2016-2022. Clients will be able to see the current status of the global mRNA Platform market, as well as the future potential competition. We can provide the revenue and sales figures for companies that you are interested in, from 2016 to 2022. mRNA Platform Research Report Includes The Following Key Players: Arcturus Therapeutic Argos Therapeutics BioNTec CureVac Etherna Ethris GlaxoSmithKline Pfizer Translate Bio Key Growth Strategies: This section examines the growth strategies of the mRNA Platform players to maintain their position, including collaborations, intensification and diversification of product portfolios and geographic expansion. This section provides information on the most recent product innovations, mergers, and acquisitions. Most Frequently Asked Questions: What are the main challenges facing mRNA Platform market players What are the top players in the mRNA Platform Market? Which regions will experience slow growth? What growth strategies are employed by mRNA Platform market players What application segment will be dominant in the future market? Which regions will offer growth opportunities in the mRNA Platform market What will the global mRNA Platform market revenues be by 2030? What are the most recent product innovations in the mRNA Platform? Which product segment is likely to see the greatest growth? Any query? Enquire Here For Discount Or Report Customization: https://market.biz/report/global-mrna-platform-market-gm/#inquiry Why Purchase mRNA Platform Market Report? This report provides a comprehensive overview of the Global mRNA Platform Industry Research Report and Growth Trends and Competitive Analysis 2023-2030. It contains the most valuable and actionable insights derived from an extensive analysis of the mRNA Platform industry. This helps to identify profitable trends and make the right decisions. The report provides benchmarking industry leaders and their pricing strategies. This report helps to identify profitable industry trends worth investing in. It also helps to identify both the short- and long-term opportunities and threats to businesses. This report is a solid, reliable source of information that will eventually lead to better and faster business decisions. Contact Us: Phone No: +1(857)4450045, +91 9130855334. American Ginseng Extract Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: https://www.pharmiweb.com/press-release/2020-10-15/american-ginseng-extract-market-business-growth-industry-research-top-key-players-survey-marketb-3 Denture Adhesives Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: https://www.pharmiweb.com/press-release/2020-10-15/denture-adhesives-market-business-growth-industry-research-top-key-players-survey-marketbiz What Is The Expected Growth Rate Of The Liquid Coffee Concentrates Market During 2022-2030? : https://eturbonews.com/what-is-the-expected-growth-rate-of-the-liquid-coffee-concentrates-market-during-2022-2030/ The Civilian Drones Market Is Expected To Grow by USD 21,619.8 Million By 2030 With a 14.3% CAGR: https://eturbonews.com/the-civilian-drones-market-is-expected-to-grow-by-usd-21619-8-million-by-2030-with-a-14-3-cagr/ Global Home Central Air Conditioners Market Is Set to Rise with the Great CAGR Rate 6.2% till 2030: https://eturbonews.com/global-home-central-air-conditioners-market-is-set-to-rise-with-the-great-cagr-rate-6-2-till-2030/ This content has been published by Market.Biz company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com . Editor Details

Translate Bio Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Translate Bio Rank

Translate Bio Frequently Asked Questions (FAQ)

  • Where is Translate Bio's headquarters?

    Translate Bio's headquarters is located at 29 Hartwell Ave, Lexington.

  • What is Translate Bio's latest funding round?

    Translate Bio's latest funding round is Acq - P2P.

  • How much did Translate Bio raise?

    Translate Bio raised a total of $150.51M.

  • Who are the investors of Translate Bio?

    Investors of Translate Bio include Sanofi, SR One, Atlas Venture, Shire, Monsanto Growth Ventures and 11 more.

  • Who are Translate Bio's competitors?

    Competitors of Translate Bio include Orna Therapeutics and 1 more.

Compare Translate Bio to Competitors

L
Laronde

Laronde provides a platform that develops Endless RNA (eRNA), an engineered form of RNA that can be programmed to express therapeutic proteins inside the body. It uses modular coding regions for infinite application versatility and non-coding regions to control expression, stability, targeting, and more. The company was founded in 2017 and is based in Cambridge, Massachusetts.

V
VaxEquity

VaxEquity is dedicated to developing saRNA-based therapeutics and vaccines for unmet medical needs.

T
Transine Therapeutics

Transine Therapeutics is developing a class of therapeutic RNAs, SINEUPs, that have the property to upregulate protein expression. SINEUPs are designed to precisely bind to a selected mRNA and boost the expression of almost any protein of choice by enhancing translation. The characteristics of SINEUPs allow the company to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. Transine's proprietary technology extends the druggable proteome and represents a mechanism of action for currently hard-to-treat diseases.

Versameb Logo
Versameb

Versameb is a regenerative medicine research and development company. Its VERSagile technology platform enables efficient development of functional mRNA molecules for customized protein expression and modification in various therapeutic indications.

O
Orna Therapeutics

Orna Therapeutics designs and delivers a class of engineered circular RNA (oRNA) therapeutics with the potential to change the way diseases are treated. Its proprietary platform combines technology to create oRNAs that drive protein expression with validated and unique delivery solutions. oRNA has advantages over traditional mRNA approaches, including simplified production, improved formula stability, and superior protein expression making it an RNA therapeutics with the potential to change patients’ lives. The company was founded in 2019 and is based in Cambridge, Massachusetts.

Strand Therapeutics Logo
Strand Therapeutics

Strand Therapeutics is an early-stage biotechnology company genetically programming mRNA to deliver therapies to improve the lives of patients.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.